Evolving concepts on the management of dyslipidaemia-Reference-Cited by-同舟云学术

Evolving concepts on the management of dyslipidaemia

Published:2019-12-17 Issue:1 Volume:75 Page:80-90
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Descamps Olivier S.¹^ORCID,Verhaegen Ann²,Demeure Fabien³,Langlois Michel⁴,Rietzschel Ernst⁵,Mertens Ann⁶,De Sutter Johan⁷^ORCID,Wallemacq Caroline⁸,Lancellotti Patrizio⁹,De Backer Guy¹⁰

Affiliation:

1. Department of internal medicine, Centres Hospitaliers Jolimont, Haine Saint-Paul and department of cardiology, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium

2. Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerpen, Belgium

3. Department of Cardiology, CHU UCL Namur site de Godinne, Yvoir, Belgium

4. department of Laboratory Medicine, Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium

5. department of Cardiology, University Hospital Ghent and Ghent University, Ghent, Belgium

6. Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging (CHROMETA), KU Leuven, Leuven, Belgium

7. Department of Cardiology, AZ Maria Middelars Ghent and University Ghent, Belgium

8. department of Diabetes, Nutrition and Metabolic diseases, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium

9. GIGA Cardiovascular Sciences, department of Cardiology, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium

10. Gent Department of public health and primary care, Ghent University, Gent, Belgium

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2019.1702823

Reference52 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

3. HDL and Cardiovascular Risk

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediterranean diet enriched with olive oil shows no consistent benefits on cardiometabolic and anthropometric parameters: a systematic review with meta-analysis of randomized controlled trials;European Journal of Nutrition;2024-08-17

2. Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting;Frontiers in Cardiovascular Medicine;2024-07-10

3. HDL abnormalities in type 2 diabetes: Clinical implications;Atherosclerosis;2023-08

4. Mediterranean Diet and Obesity-related Disorders: What is the Evidence?;Current Obesity Reports;2022-09-30

5. Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis;Cardiology Research and Practice;2022-04-26